Evidence map›Paper›PMID 40032968›Full record

ArticleScientific reports2025

Unusual presentations of myasthenia gravis and misdiagnosis.

Emel Oguz-Akarsu, Sarra El Hamida Lazrak, Gizem Gullu, Yasemin Dinç, Furkan Saridas, Necdet Karli

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Emel Oguz-AkarsuDepartment of Neurology, Uludag School of Medicine, Bursa Uludag University, Gorukle, Bursa, Turkey. emelakarsu@uludag.edu.tr.
Sarra El Hamida LazrakDepartment of Neurology, Uludag School of Medicine, Bursa Uludag University, Gorukle, Bursa, Turkey.
Gizem GulluDepartment of Neurology, Uludag School of Medicine, Bursa Uludag University, Gorukle, Bursa, Turkey.
Yasemin DinçDepartment of Neurology, Uludag School of Medicine, Bursa Uludag University, Gorukle, Bursa, Turkey.
Furkan SaridasDepartment of Neurology, Uludag School of Medicine, Bursa Uludag University, Gorukle, Bursa, Turkey.
Necdet KarliDepartment of Neurology, Uludag School of Medicine, Bursa Uludag University, Gorukle, Bursa, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myasthenia gravis (MG) poses diagnostic challenges due to its diverse clinical presentations. Diagnosing MG remains complex despite advancements, necessitating further understanding of its diverse clinical profiles. We conducted a retrospective analysis of 290 MG cases. Patient demographics, symptomatology, and diagnostic outcomes were reviewed. Patients were categorized into two groups: those displaying classical presentations and those manifesting unusual presentations. The patients with unusual presentations were comprehensively evaluated and the demographic and clinical characteristics of the two groups were compared. In our study of 290 patients with MG, 20 presented with unusual manifestations (6.9%). These included isolated dropped head, bilateral facial weakness, distal limb weakness (e.g., foot and hand drop), weakness of limb-girdle muscles, and isolated ocular findings without ptosis. When patients were categorized into two groups based on their initial symptoms, no significant differences in demographic and clinical features were observed between the classical and unusual groups, except for a higher prevalence of anti-MuSK antibodies and more frequent administration of rituximab in patients with unusual presentations. Recognizing unusual MG presentations is crucial for timely management. Our study underscores the diverse clinical spectrum of MG, emphasizing the need for nuanced diagnostic approaches and prompt intervention.

Indexed as

Diagnostic ErrorsMyasthenia GravisAdolescentAdultAgedAutoantibodiesFemaleHumansMaleMiddle AgedMuscle WeaknessReceptor Protein-Tyrosine KinasesReceptors, CholinergicRetrospective StudiesYoung AdultAutoantibodiesMUSK protein, humanReceptor Protein-Tyrosine KinasesReceptors, CholinergicMuscle-specific kinase antibodyMyasthenia gravisUnusual presentations

Identifiers

PMID40032968
PMCPMC11876431

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.